SNTI · Company research
Senti Biosciences Holdings, Inc. Common Stock (SNTI): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Senti Biosciences (SNTI) Slides 11.63% to $0.23 as Sub-$1 Biotech Faces Renewed Pressure - Fibonacci Fan - https://www.siam.in/ | Senti Biosciences (SNTI) Slides 11.63% to $0.23 as Sub-$1 Biotech Faces Renewed Pressure - Fibonacci Fan https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 16, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Holdings Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade | Senti Biosciences Holdings Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade | View source ↗ | StocksToTrade | Oct 10, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Holdings, Inc. SEC Filing (Sep 25, 2026) - Stock Titan | Senti Biosciences Holdings, Inc. SEC Filing (Sep 25, 2026) Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences (SNTI) refreshes auditor sign-off on shelf registration - Stock Titan | Senti Biosciences (SNTI) refreshes auditor sign-off on shelf registration Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences (SNTI) Gains 2.35% as Shares Hold Above Key Support at $0.36 - MAMA Signal - dars.gov.et | Senti Biosciences (SNTI) Gains 2.35% as Shares Hold Above Key Support at $0.36 - MAMA Signal dars.gov.et | View source ↗ | dars.gov.et | Aug 13, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences (SNTI) Slides 9% as Biotech Sector Headwinds Pressure Micro-Cap Stocks - Synthetic Short - dars.gov.et | Senti Biosciences (SNTI) Slides 9% as Biotech Sector Headwinds Pressure Micro-Cap Stocks - Synthetic Short dars.gov.et | View source ↗ | dars.gov.et | Jul 29, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates - kalkine.ca | Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates kalkine.ca | View source ↗ | kalkine.ca | Jul 20, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates - Kalkine | Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates Kalkine | View source ↗ | Kalkine | Jul 20, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: CPHI, SOBR, ELVA | Losers: ILLR, SNTI, SNWV - Trefis | Market Movers | Winners: CPHI, SOBR, ELVA | Losers: ILLR, SNTI, SNWV Trefis | View source ↗ | Trefis | Jul 16, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Holdings Announces Strategic Spin-Off of Gene-Circuit Pipeline and Plans Focus on Regulator Dial Platform - Quiver Quantitative | Senti Biosciences Holdings Announces Strategic Spin-Off of Gene-Circuit Pipeline and Plans Focus on Regulator Dial Platform Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 15, 2026 | neutral | 0 | 0.6 |
| SNTI Forecast — Price Target — Prediction for 2027 - TradingView | SNTI Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Secures Up to $40 Million Financing and FDA Endorsement for SENTI-202 in Relapsed/Refractory Acute Myeloid Leukemia - Quiver Quantitative | Senti Biosciences Secures Up to $40 Million Financing and FDA Endorsement for SENTI-202 in Relapsed/Refractory Acute Myeloid Leukemia Quiver Quantitative | View source ↗ | Quiver Quantitative | May 14, 2026 | neutral | 0 | 0.6 |
| Senti Biosciences Holdings (Nasdaq:SNTI) - Stock Analysis - Simply Wall Street | Senti Biosciences Holdings (Nasdaq:SNTI) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Apr 28, 2026 | neutral | 0 | 0.6 |
| SNTI Shares Surge Over 20% In Pre-Market Trade After FDA RMAT Designation For Cancer Treatment - Stocktwits | SNTI Shares Surge Over 20% In Pre-Market Trade After FDA RMAT Designation For Cancer Treatment Stocktwits | View source ↗ | Stocktwits | Dec 9, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 8, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.